Print

Alexion Pharmaceuticals Inc. (ALXN) to Present at the 24th Annual Piper Jaffray Healthcare Conference  
11/21/2012 10:41:12 AM

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at the 24th Annual Piper Jaffray Healthcare Conference in New York City at 2:30 p.m. Eastern time on Wednesday, November 28, 2012.

An audio webcast of Dr. Bell’s remarks will be available live. You can access the webcast at: www.alexionpharma.com. An archived version of the remarks will also be available through the Company’s web site for a limited time following the conference.

[ALXN-G]

Contacts

Alexion Pharmaceuticals, Inc.

Irving Adler, 203-271-8210

Executive Director, Corporate Communications

or

Media:

Alexion Pharmaceuticals, Inc.

Kim Diamond, 203-439-9600

Director, Corporate Communications

or

Investors:

Rx Communications

Rhonda Chiger, 917-322-2569


//-->